Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6634105 | 0.87 | ELANE (0.36) | ELANE | |
| SCHEMBL6635158 | 0.73 | PKM (0.41) | KMT2AMAPTALDH1A1SMN1; SMN2CYP1A2 | |
| SCHEMBL9173326 | 0.72 | KDM4E (0.33) | — | |
| SCHEMBL23833723 | 0.72 | L3MBTL1 (0.36) | KMT2AMAPTALDH1A1SMN1; SMN2L3MBTL1 | |
| SCHEMBL15127372 | 0.71 | CFD (0.34) | KMT2AMAPTALDH1A1LMNA | |
| SCHEMBL8665021 | 0.69 | KMT2A (0.39) | KMT2AMAPTMEN1ALDH1A1SMN1; SMN2 | |
| SCHEMBL6632013 | 0.69 | — | — | |
| SCHEMBL15127373 | 0.69 | POLB (0.40) | KMT2AMAPTSMN1; SMN2PKMELANE | |
| SCHEMBL4530562 | 0.69 | RAB9A (0.35) | KMT2AMAPTMEN1ALDH1A1SMN1; SMN2 | |
| SCHEMBL14999383 | 0.68 | ESR1 (0.42) | KMT2AMAPTMEN1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1286961-B1 | SULFONATED PERFLUOROVINYL FUNCTIONAL MONOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2004-05-19 | — | — | EP | disclosed |
| EP-1286961-A1 | SULFONATED PERFLUOROVINYL FUNCTIONAL MONOMERS | 3M Innovative Properties Company (US) | 2003-03-05 | — | — | EP | disclosed |
| US-6384167-B2 | MECHANICAL PROPERTIES ALONG WITH A DESIRABLE LEVEL OF IONIC CONDUCTIVITY; ION-EXCHANGE MEMBRANES | 3M INNOVATIVE PROPERTIES COMPANY | 2002-05-07 | — | — | US | disclosed |
| US-20020007083-A1 | Sulfonated perfluorovinyl functional monomers | 3M INNOVATIVE PROPERTIES COMPANY | 2002-01-17 | — | — | US | disclosed |
| WO-2001094305-A1 | SULFONATED PERFLUOROVINYL FUNCTIONAL MONOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2001-12-13 | — | — | WO | disclosed |
| US-6268532-B1 | USED FOR PREPARING SULFONATED OR NON-SULFONATED BLOCK POLYMERS | 3M INNOVATIVE PROPERTIES COMPANY | 2001-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020007083-A1 | Sulfonated perfluorovinyl functional monomers | AFF2, AFF1, FOS | KMT2A 2076/4885MAPT 4365/4885MEN1 1950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.